Correlation Between ProSomnus, Common and Neuropace

Can any of the company-specific risk be diversified away by investing in both ProSomnus, Common and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProSomnus, Common and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ProSomnus, Common Stock and Neuropace, you can compare the effects of market volatilities on ProSomnus, Common and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProSomnus, Common with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProSomnus, Common and Neuropace.

Diversification Opportunities for ProSomnus, Common and Neuropace

0.48

Correlation Coefficient

ProSomnus, Common  Neuropace

Very weak diversification

The 3 months correlation between ProSomnus, and Neuropace is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding ProSomnus, Common Stock and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and ProSomnus, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProSomnus, Common Stock are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of ProSomnus, Common i.e., ProSomnus, Common and Neuropace go up and down completely randomly.

Pair Corralation between ProSomnus, Common and Neuropace

If you would invest  739.00  in Neuropace on September 3, 2024 and sell it today you would earn a total of  321.00  from holding Neuropace or generate 43.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	3.13%
Values	Daily Returns

ProSomnus, Common Stock  vs.  Neuropace

ProSomnus, Common Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ProSomnus, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ProSomnus, Common is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Neuropace

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ProSomnus, Common and Neuropace

The main advantage of trading using opposite ProSomnus, Common and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProSomnus, Common position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind ProSomnus, Common Stock and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.